Orteronel is a nonsteroidal CYP17A1 inhibitor that was investigated as a therapeutic agent for the treatment of prostate cancer by targeting the enzyme responsible for androgen biosynthesis. This category… Read more
Orteronel is a nonsteroidal CYP17A1 inhibitor that was investigated as a therapeutic agent for the treatment of prostate cancer by targeting the enzyme responsible for androgen biosynthesis. This category provides a comprehensive selection of high-quality analytical tools, including reference standards of the Orteronel active pharmaceutical ingredient, as well as its related pharmacopeial and non-pharmacopeial impurities. These compounds are essential for laboratories conducting rigorous impurity profiling, metabolic pathway studies, and method validation during drug development. Additionally, the collection includes stable isotope labelled versions of the drug and its derivatives, which serve as critical internal standards for accurate quantification in complex biological matrices. By utilizing these precise analytical reference materials, researchers can ensure compliance with regulatory standards, optimize analytical methods, and maintain stringent quality control throughout the pharmaceutical research process.